Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Cathy W. Zbanek, Chief Synergy Officer at TFS Financial Corp (NASDAQ:TFSL), a $3.7 billion financial services company currently trading near $13.31, recently sold a portion of her holdings in the company. According to a regulatory filing, Zbanek sold 15,000 shares of common stock at a price of $13.46 per share, amounting to a total transaction value of $201,900. Following this sale, she retains direct ownership of 73,197 shares. InvestingPro analysis suggests the stock is slightly overvalued at current levels.
In addition to her directly held shares, Zbanek holds other interests in TFS Financial Corp through various plans. Her holdings include 13,760 shares indirectly owned via an Employee Stock Ownership Plan (ESOP) and 5,328 shares through a 401(k) plan. Furthermore, Zbanek has significant holdings in restricted stock units and performance restricted share units, which are contingent on future performance metrics and vesting schedules. The company maintains a notable 8.5% dividend yield and has consistently paid dividends for 12 consecutive years. For deeper insights into insider trading patterns and comprehensive financial analysis, consider subscribing to InvestingPro, which offers additional exclusive tips and metrics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.